Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
517
datasets available to search
ShareScore release 0.9.0
Dataset results
517 results for “Checkpoint inhibitors”
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
ClinicalTrials.gov study NCT06675643. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer.
ClinicalTrials.gov study NCT06923020. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy
ClinicalTrials.gov study NCT04745949. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma
ClinicalTrials.gov study NCT04189679. IPD Sharing: NO. Countries: 1. Publications: 0.
Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors
ClinicalTrials.gov study NCT03647163. IPD Sharing: NO. Countries: 1. Publications: 0.
Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr
ClinicalTrials.gov study NCT03469960. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
ClinicalTrials.gov study NCT05947669. IPD Sharing: YES. Countries: 2. Publications: 0.
Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer
ClinicalTrials.gov study NCT06368141. IPD Sharing: NO. Countries: 1. Publications: 0.
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
ClinicalTrials.gov study NCT06947928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.
ClinicalTrials.gov study NCT07090538. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of the IDH1 Inhibitor AG-120 in Combination With the Checkpoint Blockade Inhibitor, Nivolumab, for Patients With IDH1 Mutated Relapsed/Refractory AML and High Risk MDS
ClinicalTrials.gov study NCT04044209. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma Patients
ClinicalTrials.gov study NCT05102773. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05055908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients
ClinicalTrials.gov study NCT06751108. IPD Sharing: NO. Countries: 1. Publications: 0.
Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment
ClinicalTrials.gov study NCT05813418. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy
ClinicalTrials.gov study NCT05707286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors
ClinicalTrials.gov study NCT04353765. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
ClinicalTrials.gov study NCT06771544. IPD Sharing: NO. Countries: 1. Publications: 0.
Role of Renal Biopsy in the Suspicion of Nephrotoxicity of Immunotherapy (Checkpoint Inhibitors) in Solid Cancer
ClinicalTrials.gov study NCT06357871. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
ClinicalTrials.gov study NCT03544723. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.